Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
3(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
6%
Ph phase_3
3
9%
Ph phase_1
2
6%
Ph phase_4
11
32%
Ph not_applicable
6
18%
Ph phase_2
10
29%

Phase Distribution

4

Early Stage

10

Mid Stage

14

Late Stage

Phase Distribution34 total trials
Early Phase 1First-in-human
2(5.9%)
Phase 1Safety & dosage
2(5.9%)
Phase 2Efficacy & side effects
10(29.4%)
Phase 3Large-scale testing
3(8.8%)
Phase 4Post-market surveillance
11(32.4%)
N/ANon-phased studies
6(17.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

3

trials recruiting

Total Trials

34

all time

Status Distribution
Active(5)
Completed(16)
Terminated(1)
Other(12)

Detailed Status

Completed16
unknown12
Not yet recruiting2
Recruiting2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (5.9%)
Phase 12 (5.9%)
Phase 210 (29.4%)
Phase 33 (8.8%)
Phase 411 (32.4%)
N/A6 (17.6%)

Trials by Status

unknown1235%
withdrawn13%
active_not_recruiting13%
completed1647%
not_yet_recruiting26%
recruiting26%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT07706582Phase 2

Management of Iron Deficiency Anemia in Hemodialysis Patients

Active Not Recruiting
NCT05936528Phase 4

Lactoferrin Use in ICU Patients

Completed
NCT07502235Phase 3

The Effect of Lactoferrin on Pain Management Following Cesarean Section

Not Yet Recruiting
NCT05519254Phase 3

Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae

Recruiting
NCT06491394Phase 4

Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats

Completed
NCT06590831Not Applicable

Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia

Completed
NCT06427200Phase 4

Efficacy and Safety of Lactoferrin in Heart Failure Patients

Not Yet Recruiting
NCT06181422Phase 2

Metformin and Lactoferrin in Sepsis in Icu

Recruiting
NCT05921968Phase 4

Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia

Unknown
NCT05900635Phase 4

Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients

Unknown
NCT05760079Not Applicable

Lactoferrin for COVID-19-Induced Taste or Smell Abnormality

Withdrawn
NCT05714176Phase 4

Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children

Unknown
NCT05669963Phase 2

Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy

Unknown
NCT03683810Phase 1

The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia

Unknown
NCT05431023Not Applicable

Effect of Lactoferrin in Pneumonia Treatment

Unknown
NCT04860219Not Applicable

Lactoferrin Use in (SARS-CoV-2) Management

Unknown
NCT04435574Phase 4

Lactoferrin for Treatment of Iron Deficiency Anemia.

Completed
NCT04421534Phase 2

Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19

Unknown
NCT03940430Phase 2

Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students

Completed
NCT01172236Phase 4

Supplementation With Lactoferrin in Preterm Newborns

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
34